AI Buyer Insights:

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Michelin, an e2open customer evaluated Oracle Transportation Management

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Michelin, an e2open customer evaluated Oracle Transportation Management

List of Tripleblind SecuriKey Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Application Category When SI Insight
Mayo Clinic Healthcare 80221 $17.9B United States Tripleblind Tripleblind SecuriKey AML, Fraud and Compliance 2020 n/a
In 2020, Mayo Clinic collaborated with TripleBlind to validate interoperability of encrypted algorithms and to train AI on encrypted patient data for healthcare research and clinical AI in the United States. Tripleblind SecuriKey is the application name associated with this engagement, and the implementation is framed within the AML, Fraud and Compliance category while vendor materials document Privacy Builder for data de-identification in healthcare. The documented work focused on algorithm-level encryption interoperability and privacy preserving model training, enabling analysis without sharing raw PHI. TripleBlind Privacy Builder is explicitly referenced for data de-identification workflows, and the engagement validated the technical capability to run encrypted algorithms against protected health information in situ. Functional capabilities exercised include encrypted algorithm execution, secure model training on encrypted datasets, and de-identification orchestration to separate model outcomes from raw PHI. Operational coverage centered on healthcare research and clinical AI teams at Mayo Clinic in the United States, with governance implications for PHI handling and controlled algorithm sharing across institutional boundaries. Use of Tripleblind SecuriKey for AML, Fraud and Compliance workflows is inferred from the application name and category and is not publicly documented in the cited source, therefore SecuriKey is presented as an associated application rather than a documented module in this engagement. Mayo Clinic Tripleblind SecuriKey AML, Fraud and Compliance healthcare research and clinical AI.
Ping Identity Corporation Professional Services 1247 $299M United States Tripleblind Tripleblind SecuriKey AML, Fraud and Compliance 2025 n/a
In 2025, Ping Identity Corporation integrated Tripleblind SecuriKey, rebranded from Ideem, into its PingOne DaVinci identity orchestration platform. The integration embeds Tripleblind SecuriKey to provide cryptographic device binding and bank grade passkeys within PingOne DaVinci, addressing AML, Fraud and Compliance requirements for authentication and fraud prevention across financial services in the United States and globally. The implementation centers on SecuriKey modules for browser based cryptographic device binding, public key credential handling, attestation verification, and passkey lifecycle controls, configured as a modular plugin inside PingOne DaVinci orchestration flows. Tripleblind SecuriKey surfaces cryptographic assertions into authentication decisioning, enabling policy driven credential binding and stronger phishing resistant credentials as part of identity orchestration. Integration routes SecuriKey signals into PingOne DaVinci decisioning and risk workflows so authentication orchestration, fraud monitoring, and AML processes can consume device binding and passkey attestation data. Operational coverage as described targets financial services customers in the United States and international markets, impacting identity, security, fraud, and compliance functions. This record is an integration and partner announcement rather than a named bank deployment, and SecuriKey module usage for downstream financial customers is inferred from the published integration details. Governance and process work for the integration focuses on credential lifecycle policy configuration, attestation verification rules, and orchestration rule updates to route cryptographic signals into fraud detection and AML workflows.
Seqster Healthcare 250 $55M United States Tripleblind Tripleblind SecuriKey AML, Fraud and Compliance 2022 n/a
In 2022, Seqster announced a partnership with TripleBlind to enable de-identified, tokenized, real-time health data sharing and analysis across EHRs, genomics, wearables and other sources in the United States. The announcement documents use of TripleBlind's privacy-preserving data collaboration capabilities to advance healthcare data interoperability between clinical and research stakeholders. The public disclosure references privacy and tokenization workflows and implies potential adoption of Tripleblind SecuriKey to support controls aligned to AML, Fraud and Compliance, while the source does not explicitly state a SecuriKey deployment. Tripleblind SecuriKey is described here as the named application tied to the partnership, and if implemented it would typically provide key management, tokenization, and privacy-preserving access controls that map to AML, Fraud and Compliance functional terminology. Operational scope described in the announcement centers on cross-source integrations across electronic health records, genomic repositories, and consumer wearable streams to enable governed, de-identified analytics. Governance signals emphasize consented data sharing, token lifecycle management, and controlled analytic access, indicating process changes around privacy-first interoperability rather than detailing specific AML program workflows.
Education 18800 $3.0B United States Tripleblind Tripleblind SecuriKey AML, Fraud and Compliance 2023 n/a
Showing 1 to 4 of 4 entries

Buyer Intent: Companies Evaluating Tripleblind SecuriKey

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Tripleblind SecuriKey. Gain ongoing access to real-time prospects and uncover hidden opportunities.

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD Tripleblind SecuriKey Coverage

Tripleblind SecuriKey is a AML, Fraud and Compliance solution from Tripleblind.

Companies worldwide use Tripleblind SecuriKey, from small firms to large enterprises across 21+ industries.

Organizations such as Mayo Clinic, UT Southwestern Medical Center, Ping Identity Corporation and Seqster are recorded users of Tripleblind SecuriKey for AML, Fraud and Compliance.

Companies using Tripleblind SecuriKey are most concentrated in Healthcare, Education and Professional Services, with adoption spanning over 21 industries.

Companies using Tripleblind SecuriKey are most concentrated in United States, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Tripleblind SecuriKey across Americas, EMEA, and APAC.

Companies using Tripleblind SecuriKey range from small businesses with 0-100 employees - 0%, to mid-sized firms with 101-1,000 employees - 25%, large organizations with 1,001-10,000 employees - 25%, and global enterprises with 10,000+ employees - 50%.

Customers of Tripleblind SecuriKey include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified Tripleblind SecuriKey customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of AML, Fraud and Compliance.